The Pfizer vaccine has prevented 94 per cent of recipients in Israel from getting symptoms in a huge peer-reviewed study of 1.2 million people. The experiment took place between December 20 and February 1 - a period when the British mutant strain of Covid was rampant, making the vaccine's performance all the more impressive. The paper published in the New England Journal of Medicine marks the latest victory for Israel ...